The leading scientist urging policymakers not to criminalize kratom, a substance that has left a trail of death and addiction ...
Infectious disease specialists are sounding the alarm about a Trump administration plan to eliminate a clinical research unit ...
It's been almost a month since Sen. Mitch McConnell (R-Ky.) last shared a health update, leading to another round of ...
The FDA approved ropeginterferon alfa-2b (Besremi) injection to treat adults with essential thrombocythemia, the first new ...
GLP-1 receptor agonists may be powerful tools for treating obesity and cardiometabolic disease, but relying on medications ...
William Flanary, MD, an ophthalmologist better known as Dr. Glaucomflecken, stirred online debates among physicians after his ...
Valmed in diagnosing rheumatologic conditions. Use of Prof. Valmed did not improve diagnostic accuracy but reduced the time ...
The FDA warned that Boston Scientific's recalled spinal cord stimulator for chronic limb pain has been linked to 1,081 ...
The systematic review and meta-analysis included 162 studies and data for 316,131 people and 11,822 patients with unruptured ...
A judge declared a mistrial in the Lindsay Clancy murder trial on Friday after jurors said they could not reach a unanimous ...
It makes sense for optometrists to monitor patients with wet AMD for signs of worsening, Dunbar said, especially in light of ...
Prescriptions for GLP-1 drugs surged 310-fold (from 0.03% to 9.3%) among kids ages 8 to 11 with obesity, despite a lack of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results